Importance of maintaining the relative dose intensity of CHOP-like regimens combined with rituximab in patients with diffuse large B-cell lymphoma

By Hirakawa Tsuneaki   Yamaguchi Hiroki   Yokose Norio   Gomi Seiji   Inokuchi Koiti   Dan Kazuo  

Annals of Hematology, Vol. 89, Iss. 9, 2010-09 ,pp. : 897-904

Springer Publishing Company

Access to resources Recommend Favorite

Association of reduced relative dose intensity and survival in lymphoma patients receiving CHOP-21 chemotherapy

By Pettengell R.  

Annals of Hematology, Vol. 87, Iss. 5, 2008-05 ,pp. : 429-430

Springer Publishing Company

Access to resources Recommend Favorite

Reassessment of the prognostic factors of international prognostic index (IPI) in the patients with diffuse large B-cell lymphoma in an era of R-CHOP in Chinese population

By Yang Shen  

Annals of Hematology, Vol. 88, Iss. 9, 2009-09 ,pp. : 863-869

Springer Publishing Company

Access to resources Recommend Favorite

Clinical impact of bulky mass in the patient with primary extranodal diffuse large B cell lymphoma treated with R-CHOP therapy

By Song Moo-Kon   Chung Joo-Seop   Sung-Yong Oh   Lee Gyeong-Won   Kim Seung-Geun   Seol Young-Mi   Shin Ho-Jin   Choi Young-Jin   Cho Goon-Jae   Shin Dong-Hoon   Yun Eun-Young  

Annals of Hematology, Vol. 89, Iss. 10, 2010-10 ,pp. : 985-991

Springer Publishing Company

Access to resources Recommend Favorite

Rituximab in combination with CHOP chemotherapy for the treatment of diffuse large B cell lymphoma in Chinese patients

By Li J.   Wang L.   Shen Y.   Xia Z.   Chen Y.   Chen Q.   Chen Y.   Zeng X.   You J.   Qian Y.   Shen Z.  

Annals of Hematology, Vol. 86, Iss. 9, 2007-09 ,pp. : 639-645

Springer Publishing Company

Access to resources Recommend Favorite